Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors.
文献类型：期刊论文
| 作者 | Bai, Chunmei; Xu, Jianming; Shen, Lin; Li, Jie; Zhou, Zhiwei ; Chi, Yihebali; Li, Zhiping; Xu, Nong; Li, Enxiao; Liu, Tianshu
|
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2020-05-20 |
| 卷号 | 38 |
| ISSN号 | 0732-183X |
| 资助项目 | Hutchison MediPharma Limited |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000560368302226 |
| 出版者 | AMER SOC CLINICAL ONCOLOGY |
| 资助机构 | Hutchison MediPharma Limited |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/104220]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Zhejiang Canc Hosp, Hangzhou, Peoples R China 2.Peking Union Med Coll Hosp, Beijing, Peoples R China 3.Gen Hosp Peoples Liberat Army, Med Ctr 5, Dept Gastrointestinal Oncol, Beijing, Peoples R China 4.Peking Univ Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China 5.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 6.Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China 7.West China Hosp, Chengdu, Peoples R China 8.Zhejiang Univ, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Peoples R China 9.Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Peoples R China 10.Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Bai, Chunmei,Xu, Jianming,Shen, Lin,et al. Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors.[J]. JOURNAL OF CLINICAL ONCOLOGY,2020,38. |
| APA | Bai, Chunmei.,Xu, Jianming.,Shen, Lin.,Li, Jie.,Zhou, Zhiwei.,...&Su, Weiguo.(2020).Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors..JOURNAL OF CLINICAL ONCOLOGY,38. |
| MLA | Bai, Chunmei,et al."Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors.".JOURNAL OF CLINICAL ONCOLOGY 38(2020). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。